Westwood Bioscience

Westwood Bioscience

Biotechnology, Los Angeles, California, 10029, United States, 1-10 Employees

westwoodbioscience.com

  • LinkedIn

phone no Phone Number: 31********

Who is WESTWOOD BIOSCIENCE

Liposomal delivery of small molecules has been hampered by toxicity, poor circulatory half-life, API leakage, and challenges in achieving controlled incorporation of multiple drugs in one...

Read More

map
  • Los Angeles, California, 10029, United States Headquarters: Los Angeles, California, 10029, United States
  • 2018 Date Founded: 2018
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $1 Billion and Over
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2836 | NAICS Code: 541714 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from WESTWOOD BIOSCIENCE

Westwood Bioscience Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Westwood Bioscience

Answer: Westwood Bioscience's headquarters are located at Los Angeles, California, 10029, United States

Answer: Westwood Bioscience's phone number is 31********

Answer: Westwood Bioscience's official website is https://westwoodbioscience.com

Answer: Westwood Bioscience's revenue is $1 Billion and Over

Answer: Westwood Bioscience's SIC: 2836

Answer: Westwood Bioscience's NAICS: 541714

Answer: Westwood Bioscience has 1-10 employees

Answer: Westwood Bioscience is in Biotechnology

Answer: Westwood Bioscience contact info: Phone number: 31******** Website: https://westwoodbioscience.com

Answer: Liposomal delivery of small molecules has been hampered by toxicity, poor circulatory half-life, API leakage, and challenges in achieving controlled incorporation of multiple drugs in one product. Silicasomes are comprised of a mesoporous silica core that, under optimized conditions, contain a multitude of hollow spiral tubes a bit like a sponge. Size and particle distribution of this bare mesoporous nanoparticle (MNSP) can be carefully and reproducibly controlled. A protonating agent is added to the MNSP which are then coated with a single lipid bilayer. The lipid bilayer protects the MNSP while in the circulation and helps prevent leakage of the drug payload. One or more drugs can then be added to the MNSP, to the lipid bilayer or to both, in a very controlled ratiometric manner. All components of the Silicasome are bio-degradable or absorbable and are non-toxic. In animal models, irinotecan-loaded Silicasomes demonstrated increased efficacy and virtually no toxicity as compared to free irinotecan or a marketed liposome-delivered formulation, including in very challenging mouse models bearing human tumors. With better efficacy and no demonstrable toxicity in animal studies, and significantly improved drug loading capacity, drug retention and stability as compared to traditional liposomal delivery technologies, Silicasomes provide the technology for Westwood to become a leader in drug delivery. We are currently pursuing oncology opportunities with a lead product intended to target pancreatic, colon cancers and lung cancers.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access